Ye Z, Xu J, Zhang X, Zhang Y, Ivanova D, Lu W
Int J Mol Sci. 2024; 25(12).
PMID: 38928496
PMC: 11203551.
DOI: 10.3390/ijms25126792.
Konstantis G, Tsaousi G, Pourzitaki C, Kasper-Virchow S, Zaun G, Kitsikidou E
Cancers (Basel). 2024; 16(7).
PMID: 38610959
PMC: 11010876.
DOI: 10.3390/cancers16071280.
Huang Y, Fan H, Ti H
Asian J Pharm Sci. 2024; 19(2):100902.
PMID: 38595331
PMC: 11002556.
DOI: 10.1016/j.ajps.2024.100902.
Lacinski R, Dziadowicz S, Stewart A, Chaharbakhshi E, Akhter H, Pisquiy J
iScience. 2024; 27(2):108836.
PMID: 38303687
PMC: 10831265.
DOI: 10.1016/j.isci.2024.108836.
Wang Y, Liu H, Zhang Z, Bian D, Shao K, Wang S
J Immunother Cancer. 2023; 11(6).
PMID: 37364932
PMC: 10410840.
DOI: 10.1136/jitc-2022-006166.
[Advances of Immunotherapy Resistance and Coping Strategies
in Non-small Cell Lung Cancer].
Jing Y, Zeng H, Cheng R, Tian P, Li Y
Zhongguo Fei Ai Za Zhi. 2023; 26(1):66-77.
PMID: 36792083
PMC: 9987066.
DOI: 10.3779/j.issn.1009-3419.2023.102.03.
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
Wu Y, Yi M, Niu M, Mei Q, Wu K
Mol Cancer. 2022; 21(1):184.
PMID: 36163047
PMC: 9513992.
DOI: 10.1186/s12943-022-01657-y.
Monocytic MDSCs homing to thymus contribute to age-related CD8+ T cell tolerance of HBV.
Fang Z, Zhang Y, Zhu Z, Wang C, Hu Y, Peng X
J Exp Med. 2022; 219(4).
PMID: 35254403
PMC: 8906470.
DOI: 10.1084/jem.20211838.
Analysis of the myeloid-derived suppressor cells and annexin A1 in multibacillary leprosy and reactional episodes.
da Silva S, Cavalcante L, Fonseca Junior E, Silva J, Lopes J, Damazo A
BMC Infect Dis. 2021; 21(1):1050.
PMID: 34627197
PMC: 8502368.
DOI: 10.1186/s12879-021-06744-x.
Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression.
Gao Y, Xu H, Li N, Wang H, Ma L, Chen S
Cell Commun Signal. 2020; 18(1):106.
PMID: 32641056
PMC: 7341585.
DOI: 10.1186/s12964-020-00611-z.
Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors.
Hou A, Hou K, Huang Q, Lei Y, Chen W
Front Immunol. 2020; 11:783.
PMID: 32508809
PMC: 7249937.
DOI: 10.3389/fimmu.2020.00783.
Nanoengineered targeting strategy for cancer immunotherapy.
Yin W, Li Y, Gu Y, Luo M
Acta Pharmacol Sin. 2020; 41(7):902-910.
PMID: 32398683
PMC: 7470800.
DOI: 10.1038/s41401-020-0417-3.
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy.
Baumann D, Hagele T, Mochayedi J, Drebant J, Vent C, Blobner S
Nat Commun. 2020; 11(1):2176.
PMID: 32358491
PMC: 7195409.
DOI: 10.1038/s41467-020-15979-2.
Tumor immune microenvironment in head and neck cancers.
Chen S, Krinsky A, Woolaver R, Wang X, Chen Z, Wang J
Mol Carcinog. 2020; 59(7):766-774.
PMID: 32017286
PMC: 7282929.
DOI: 10.1002/mc.23162.
Tasquinimod targets suppressive myeloid cells in the tumor microenvironment.
Shen L, Pili R
Oncoimmunology. 2019; 8(10):e1072672.
PMID: 31646064
PMC: 6791429.
DOI: 10.1080/2162402X.2015.1072672.
One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockade.
Gupta A, Budhu S, Merghoub T
Hepatobiliary Surg Nutr. 2019; 8(3):289-294.
PMID: 31245417
PMC: 6561888.
DOI: 10.21037/hbsn.2019.01.10.
Genetics and biology of prostate cancer.
Wang G, Zhao D, Spring D, DePinho R
Genes Dev. 2018; 32(17-18):1105-1140.
PMID: 30181359
PMC: 6120714.
DOI: 10.1101/gad.315739.118.
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.
Blazar B, MacDonald K, Hill G
Blood. 2018; 131(24):2651-2660.
PMID: 29728401
PMC: 6032895.
DOI: 10.1182/blood-2017-11-785865.
Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice.
Chiasson V, Bounds K, Chatterjee P, Manandhar L, Pakanati A, Hernandez M
Hypertension. 2017; 71(1):199-207.
PMID: 29133357
PMC: 5730469.
DOI: 10.1161/HYPERTENSIONAHA.117.10306.
Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8 T cell responses during acute Friend retrovirus infection.
Drabczyk-Pluta M, Werner T, Hoffmann D, Leng Q, Chen L, Dittmer U
Retrovirology. 2017; 14(1):42.
PMID: 28835242
PMC: 5569525.
DOI: 10.1186/s12977-017-0364-3.